Higher Bar for IBD Control Achievable With Omvoh, Lilly Data Suggest
LUCENT-2 and VIVID-1 post-hoc data show Omvoh enabled comprehensive disease control and corticosteroid-free deep remission in IBD at one year.
Already have an account? Sign in.